Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2015 / Feb / Five Things We Learned This Month:

Five Things We Learned This Month:

2/18/2015 1 min read

Share

1. Drusen Contain Calcium Spheres Tiny spherules of hydroxyapatite – bone mineral – have been discovered in drusen, and researchers suspect they might initiate and catalyze drusen and basal laminar deposit formation, by providing a scaffold for common drusen proteins to adhere. 2. The First Mutation in Heritable OMS Has Been Found A gene, PNPLA6, thought to be responsible for certain heritable cases of Leber Congenital Amaurosis and Oliver-McFarlane Syndrome has just been identified – and helps us better understand some of the cellular processes involved in retinal degeneration. 3. Up To 15 percent of Patients Are “Poor Responders” to Anti-VEGF A recent study identified one possible cause of poor response to anti-VEGF drugs in the retina: obstructive sleep apnea (OSA). Patients with AMD and DME are far more likely to respond poorly to bevacizumab if they also have a high risk of OSA. 4. A Quarter of all Published Articles on Cone Dystrophy are Basic Research This month, The Ophthalmologist benchmarked the last five years of PubMed-listed abstracts on cone dystrophy. We found that 25 percent of all articles were basic research, 38 percent were case reports/ case series, and just two percent were clinical trials. 5. The Best Ways to Assess Postoperative Visual Performance Assessing patients’ refraction following monofocal IOL placement was relatively simple –but it’s a whole different ballgame with the advanced optics of premium IOLs. Florian Kretz shared his tips for optimal assessment.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: